Lysyl-phosphatidylglycerol attenuates membrane perturbation rather than surface association of the cationic antimicrobial peptide 6W-RP-1 in a model membrane system: implications for daptomycin resistance. - Wikidata - wikimedia - TriplyDB

Lysyl-phosphatidylglycerol attenuates membrane perturbation rather than surface association of the cationic antimicrobial peptide 6W-RP-1 in a model membrane system: implications for daptomycin resistance.

Lysyl-phosphatidylglycerol attenuates membrane perturbation rather than surface association of the cationic antimicrobial peptide 6W-RP-1 in a model membrane system: implications for daptomycin resistance.

http://www.wikidata.org/entity/Q34151075

about

Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity Lysylated phospholipids stabilize models of bacterial lipid bilayers and protect against antimicrobial peptides.D-alanylation of lipoteichoic acids confers resistance to cationic peptides in group B streptococcus by increasing the cell wall density Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis.Genetic basis for in vivo daptomycin resistance in enterococci.The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides.Bactericidal Effects and Mechanism of Action of Olanexidine Gluconate, a New Antiseptic.Photoinactivation of Staphylococcus aureus using protoporphyrin IX: the role of haem-regulated transporter HrtA.Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus.Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall.A current perspective on daptomycin for the clinical microbiologist.Comparative Genome Analysis of the Daptomycin-Resistant Streptococcus anginosus Strain J4206 Associated with Breakthrough Bacteremia.Membrane lipids in Agrobacterium tumefaciens: biosynthetic pathways and importance for pathogenesis.Reduction in membrane phosphatidylglycerol content leads to daptomycin resistance in Bacillus subtilis.Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci Comparing the action of HT61 and chlorhexidine on natural and model Staphylococcus aureus membranes.Evaluation of telavancin activity versus daptomycin and vancomycin against daptomycin-nonsusceptible Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model Binding of Daptomycin to Anionic Lipid Vesicles Is Reduced in the Presence of Lysyl-Phosphatidylglycerol Untargeted metabolomics analysis revealed changes in the composition of glycerolipids and phospholipids in Bacillus subtilis under 1-butanol stress.Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocar Differential adaptive responses of Staphylococcus aureus to in vitro selection with different antimicrobial peptides.Multiple peptide resistance factor (MprF)-mediated Resistance of Staphylococcus aureus against antimicrobial peptides coincides with a modulated peptide interaction with artificial membranes comprising lysyl-phosphatidylglycerol.Reversible daptomycin tolerance of adherent staphylococci in an implant infection model.Staphylococcus aureus CidC Is a Pyruvate:Menaquinone Oxidoreductase.Exposure of Methicillin-Resistant Staphylococcus aureus to Low Levels of the Antibacterial THAM-3ΦG Generates a Small Colony Drug-Resistant Phenotype.

P2860

Q31131146-0B1DB70E-BC57-4E7A-BD06-BA0F4FBFAB62 Q33939055-CB9CC332-8FD3-4A0D-B006-C03EAFF4C509 Q33987578-948AAD9C-2F83-4996-A3D2-1443C054C4CE Q34411837-EA6DB070-E759-40F7-9994-72A4B94A3A48 Q34597770-3CBBBA14-B430-4F5B-97B3-C6029B76E191 Q35191555-0D805588-9080-4C85-9145-767877029C07 Q35256159-EF057CAE-A22E-436D-9B6B-3BFF020D81DD Q35473516-C5EA4A56-4B23-4C0D-B5B8-4537682B0009 Q35499202-5A8D3340-8EEE-49FD-A081-1DF65F57B620 Q35665343-0C58362E-3553-4F40-A3DE-57E798349B0B Q35860033-9E8F1795-51AD-447E-A708-2688CABA0CE1 Q36474873-0A68B032-FAB0-47E4-80A8-4B25C8DCFF87 Q36558432-ADFD23B7-19D8-4CD7-9DED-BE1879DCE3D1 Q36565462-EC39E060-C8C5-4A3F-9431-4DB47B25C36F Q37263289-28B63303-2304-4829-9A95-F44E8E953758 Q37547326-D94F2E6F-82DB-48FC-AC4E-F806760E7D40 Q38203880-4A9B3D37-0B1A-4CC1-91A2-6C34B25FE326 Q38282693-21F195C8-A668-45B4-BB8C-BB73F179F8FF Q38942573-C4E2B7D8-B9C0-4F74-B04A-0AC13FD58B22 Q40110502-B1E5E3DE-512D-4978-9D2E-8B7477B49816 Q40602795-A3A04205-1B68-4FC8-B5A6-D9E31146D7B1 Q40662905-8F56BBBE-740E-4350-A48A-31225BEA2057 Q40889328-2D84C491-657B-47A1-B5FD-27EA70E76C8F Q41570351-1101324B-7C5F-462E-975E-DE1B9B168100 Q41874633-AA9DA6CC-2422-4CC9-BE04-756CE3CEC0D5 Q42737621-A83239C9-80A2-4D2D-BBAA-94D6E41DDD5B Q42772389-E8F82F41-40C7-4196-995B-9209209B0A06 Q47801547-741B58A2-223E-4F5A-BB00-52DB86FA49CA Q55502239-E49B221E-90B4-4644-973B-5F3E2D31F316

P2860

Lysyl-phosphatidylglycerol attenuates membrane perturbation rather than surface association of the cationic antimicrobial peptide 6W-RP-1 in a model membrane system: implications for daptomycin resistance.

http://www.wikidata.org/entity/Q34151075

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Lysyl-phosphatidylglycerol att ...... ons for daptomycin resistance.

@ast

Lysyl-phosphatidylglycerol att ...... ons for daptomycin resistance.

@en

Lysyl-phosphatidylglycerol att ...... ons for daptomycin resistance.

@nl

type

label

Lysyl-phosphatidylglycerol att ...... ons for daptomycin resistance.

@ast

Lysyl-phosphatidylglycerol att ...... ons for daptomycin resistance.

@en

Lysyl-phosphatidylglycerol att ...... ons for daptomycin resistance.

@nl

prefLabel

Lysyl-phosphatidylglycerol att ...... ons for daptomycin resistance.

@ast

Lysyl-phosphatidylglycerol att ...... ons for daptomycin resistance.

@en

Lysyl-phosphatidylglycerol att ...... ons for daptomycin resistance.

@nl

P1433

Q34151075-CE7CD82E-AC84-4D13-BCA7-167CDC90A8F2

P1476

Q34151075-5A110B2E-86F8-4FFC-AD0F-CE9D6E7CF8B1

P2093

Q34151075-992BD4FE-61D7-42CA-8C71-13A792B16346

Q34151075-AEA3C091-10B1-44E1-B2F7-6691363B07C6

Q34151075-DBD02FAD-EB00-4568-AF09-A0BA0F59F014

Q34151075-DDCB663D-461D-4B4A-858A-FBC5EC475ABE

P2860

Q34151075-07B73B44-58D8-4A61-B3F9-65ED01FE6A13

Q34151075-0AF65151-35FA-46B5-9C58-207248FC5014

Q34151075-119A7511-E3A3-46FA-903F-6523566D6C22

Q34151075-1D710CCD-AE82-4935-B18E-868B7C7255D3

Q34151075-37273AFC-6A00-4B2F-A9EC-20880D104BC2

Q34151075-480BCF34-53B6-4D71-AD48-F87800BCB7D9

Q34151075-591D9167-0EDE-4C4B-A41E-1EFBF7CBA3D0

Q34151075-5A774458-3334-4C5D-9A9D-5577ADAC83CA

Q34151075-6A6F19E9-537A-4D03-B9B2-119CD00A1AFA

Q34151075-7046D949-41F9-42BD-AB8F-BA528809FCFE

P304

Q34151075-C683371C-C5FC-4C89-9CA9-8C43EB3AAAE6

P31

Q34151075-2DBB4ABF-F5AA-48FA-992E-9F24392A3258

P356

Q34151075-1BE046A8-BCDE-4A16-A670-5C5C9FF3666C

P407

Q34151075-8ACD2FB9-8A75-44A3-9DB4-BE37B219C7B4

P433

Q34151075-2B97F764-9CF0-41AD-98A6-91629370CBF8

P478

Q34151075-92E464AC-AE1C-4E15-AC12-E96C7C67EE85

P577

Q34151075-6C4B2A7D-CBC0-41CB-8199-122609FD4CB6

P698

Q34151075-A38CFCDB-053F-478E-A63F-9551864E3DF1

P921

Q34151075-D0902CCF-C7AB-4DE7-A172-BA73D84776B7

P932

Q34151075-D39F26AF-210A-44BA-8B5F-9FB965C3205C

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Lysyl-phosphatidylglycerol att ...... ons for daptomycin resistance.

@en

P2093

Antje Pokorny

http://www.w3.org/2001/XMLSchema#string

Arnold S Bayer

http://www.w3.org/2001/XMLSchema#string

Erin Kilelee

http://www.w3.org/2001/XMLSchema#string

Michael R Yeaman

http://www.w3.org/2001/XMLSchema#string

P2860

Peptide induced demixing in PG/PE lipid mixtures: a mechanism for the specificity of antimicrobial peptides towards bacterial membranes?

Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus.

DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model.

Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices

Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine

Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding.

A quantitative model for the all-or-none permeabilization of phospholipid vesicles by the antimicrobial peptide cecropin A.

RNA-dependent lipid remodeling by bacterial multiple peptide resistance factors.

Aminoacyl-tRNAs, the bacterial cell envelope, and antibiotics

Metabolism of phosphatidylglycerol, lysylphosphatidylglycerol, and cardiolipin of Staphylococcus aureus.

P304

4476-4479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00191-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20660664

http://www.w3.org/2001/XMLSchema#string

P921

antimicrobial resistance

P932

2944598

http://www.w3.org/2001/XMLSchema#string